Wegovy (semaglutide) is one of the many Weight Loss Products we sell at Medsforless. It is an injectable medication designed for weight loss in individuals with a BMI exceeding 30. It’s also prescribed for those with a BMI over 27 who have accompanying weight-related health issues such as high blood pressure, diabetes, heart disease, and elevated cholesterol levels. By mimicking a natural hormone in the gut, Wegovy aids in appetite control and induces a sensation of fullness.
to receive your order on Thursday March 27, 2025
£159.99 – £796.99
Wegovy is a prescription weight loss medication that is primarily in the treatment of obesity.
It contains the active ingredient Semaglutide which helps to reduce appetite, maintain a feeling of fullness in the stomach and reduce cravings.
Wegovy is taken as an injectable medicine once a week and is quick and easy to use.
Buying Wegovy online is now easier than before, you can safely, reliably and easily from Meds for Less and expect delivery to your home address within 24 hours.
Wegovy is a prescription, injectable medication that is used primarily for the treatment of obesity and weight management. It contains the active ingredient Semaglutide, a synthetic product which mimics the natural hormone, Glucagon-like peptide-1 (GLP-1).
In the context of obesity, GLP-1 helps regulate appetite and reduce food intake by acting on appetite centres in the brain. This helps people feel fuller sooner, reduces cravings, helps people eat less and allows for weight loss.
Some diabetes control medications also use the active ingredient Semaglutide for their purposes, however the dose of Semaglutide is higher in Weight loss medications like Wegovy than in diabetes medications, like Ozempic.
Please find the Injectable Wegovy Cost of purchase in the table below according to the dosage and number of injections available.
Wegovy Dose | 1-month supply | 2-month supply | 3-month supply |
0.25 mg | £159.99 | £318.99 | £477.99 |
0.5 mg | £159.99 | £318.99 | £477.99 |
1 mg | £159.99 | £318.99 | £477.99 |
1.7 mg | £223.99 | £445.99 | £668.99 |
2.4 mg | £267.99 | £529.99 | £796.99 |
Wegovy and Saxenda are both injectable weight loss medications, however they differ in their active ingredients, dosing, effectiveness and administration schedules.
Wegovy contains the active ingredient Semaglutide which helps to reduce appetite, promote a feeling of fullness and reduce food intake. Saxenda uses the active ingredient, Liraglutide which also promotes a feeling of fullness and reduces cravings for food, however it has a shorter duration of action compared to Semaglutide.
Due to having a longer dose of action, the maintenance dose of Wegovy only needs to be administered once a week however the shorter acting Liraglutide needs to have its maintenance dose taken once a day.
Wegovy has shown to have a 15-20% effectiveness in weight loss in a year when combined with diet and exercise. Saxenda’s effectiveness averages around 5-10% loss of initial body weight over a year.
Saxenda and Wegovy are approved for use in individuals who have a BMI of 30 kg/m2 (classified obese) or BMI of 27 kg/m2 with a weight related condition (like hypertension or type II diabetes).
In countries including the UK, Saxenda has been approved for the use of adults and adolescents (from 12 and above) with obesity whereas Wegovy is only approved for the use of adults (18 and above).
Both, Saxenda and Wegovy have similar side effect profiles since both medicines have active ingredients which act as GLP-1 mimetics. These side effects tend to include nausea, vomiting, constipation, headache and gut discomfort. The side effects are usually more prominent at the start of treatment or during dose increases.
Wegovy is a prescription injectable medication with an initial dose of 0.25 mg once weekly for the first month. Dose increases occur once every 4 weeks until a maintenance dose of 2.4mg once weekly is reached. A sample dosing timetable is given below:
Weeks 0-4: 0.25mg once weekly
Week 5-8: 0.5 once weekly
Week 9-12: 1mg once weekly
Week 13-16: 1.7mg once weekly
Week 17 onwards: maintenance dose of 2.4mg once weekly
The low initial dose and subsequent gradual increase helps patients tolerate the effects and side effects of the medication. Please speak to your healthcare provider about the appropriate dosing and administration schedule for the Injectable Wegovy pen.
Wegovy comes as injectable pen with a certain fixed supply of doses. The pen can be
injected under the skin (subcutaneously) in areas like the abdomen, thigh and upper arm. Wegovy should be taken on the same day each week but it can be taken anytime of the week, with or without food.
WeGovy can help with other conditions, particularly those related to obesity as the effects of weight management can improve metabolic health and reduce the risk factors for other diseases.
Wegovy’s active ingredient Semaglutide can be used in diabetes treatment as demonstrated by diabetes medications Ozempic and Rybelsus . Semaglutide, in its function as a GLP-1 mimetic, increases insulin sensitivity of the body’s cells and insulin secretion by the pancreas.
This is in addition to the helpful weight loss effects it exerts by decreasing appetite leads to a combination effect that can help regulate and reduce blood sugars and help treat diabetes.
Wegovy can help treat Non-alcoholic Fatty Liver Disease (NAFLD), a condition normally associated with obesity and insulin resistance. Wegovy’s ability to increase insulin sensitivity and cause weight loss can be very helpful in treating NAFLD.
Obesity is a major risk factor for heart disease, and high blood pressure, Wegovy’s weight loss effects can help lower blood pressure, lower cholesterol levels and overall cardiovascular strain.
Wegovy’s weight loss effects can also help reduce the severity and effects of conditions like Obstructive Sleep Apnoea, Joint pain and Osteoarthritis, as well as Polycystic Ovary Syndrome.
Wegovy contains the active ingredient Semaglutide at a dose that is meant for weight loss. It has been proven in clinical trials to help people loose 15-20% of their body weight within 68 weeks (1 + year) when combined with a reduced calorie diet and increase physical activity.
Lifestyle changes alone were shown to only have a 5-10% effect on weight loss. Semaglutide’s effect on reducing appetite and increasing satiety can also make it easier to stick to a reduced calorie diet by helping increase the feeling of fullness in the body.
Wegovy has some contraindications (situations it shouldn’t be used in) and potential drug interactions.
Contraindications for Wegovy include:
Medications to use with caution due to the potential of drug interaction include:
Wegovy is not recommended to be taken during pregnancy due to the potential risks to the developing fetus. Although very few human studies have been performed on the effects of Semaglutide (Wegovy’s active ingredient) in pregnancy, animal studies have shown that Semaglutide to be harmful to the developing fetus.
Women who are on Wegovy and are thinking of trying to conceive are advised to discontinue Wegovy atleast 2 months before trying to conceive.
Aside from Semaglutide/Wegovy’s potential harmful effects on the womb, intentional weight loss (even through other methods) are not recommended during pregnancy due to the independent effect of weight loss on the developing fetus.
Like most medications, Wegovy has a range of side effects that can vary in intensity and type. The more common side effects are typically less serious however the less common side effects tend to be a bit more severe.
Common side effects include:
Rarer but more serious side effects include:
If you experience any of the rarer yet more serious side effects of Wegovy, please seek medical attention immediately.
There are some alternatives to Wegovy that can be used for weight loss by affecting appetite and metabolic pathways, these options include:
1. Ozempic
2. Wegovy.
3. Saxenda
4. Mounjaro
5. Orlistat
For finding out about other alternatives to Wegovy, or other methods of weight loss or diabetes control, please speak to your healthcare provider.
You can purchase Wegovy (semaglutide) in the UK, however there are some restrictions on it’s purchase due to being a powerful prescription medication. There are also limits on availability due to an increased demand and limited supply.
Wegovy is prescribed sparingly and the criterion for prescription is adults who have a BMI of 30 or more, or 27 or more with other weight-related health conditions like diabetes or hypertension.
While Wegovy is available on the NHS for some people who meet strict eligibility criteria, it can also be obtained privately and individually from health clinics and pharmacies if one meets the health guidelines.
You can order Wegovy online From Meds For Less easily, reliably and conveniently for the next day delivery to your home address.
Wegovy cannot be bought Over The Counter (OTC) as it as a prescription medication and can only be prescribed from a qualified healthcare professional.
The active ingredient, Semaglutide is a powerful GLP-1 mimetic which significantly affects appetite and blood sugar levels and hence safe prescriptions with regular monitoring for its effects and potential side effects is needed.
A more affordable medical alternative to Wegovy can be Ozempic, a diabetes medication that also uses Semaglutide as an active ingredient.
Ozempic contains lower concentrations of Semaglutide than Wegovy as its primary use is for sugar control as opposed for weight loss.
Healthcare providers can prescribe Ozempic off-label for weight management due to Semaglutide’s ability to reduce appetite and weight loss.
The dosing of Ozempic is slightly different than that of Wegovy so its necessary to follow a healthcare provider’s schedule for how to use Ozempic for weight loss.
Due to Wegovy’s popularity as an effective weight loss medication and a limited supply, there has been a shortage in many countries including the United Kingdom.
A high demand for the drug and limited production by the manufacturer has created a supply-demand imbalance and constraints on access to the drug.
Additionally, due to being a powerful weight loss medication, there are strict eligibility criteria for the prescription of Wegovy. This can make it slightly more difficult to obtain a prescription for Wegovy.
You can buy Wegovy injections online from Meds For Less easily, conveniently and reliably.
Simply fill out a confidential form about your medical needs, this will be reviewed by a GMC registered doctor who will then authorize the medication as appropriate and allow it to be dispatched to your home address.
Wegovy has been shown to help people lose an average of 15-20% of their initial body weight over 6-12 months when combined with lifestyle changes such as dietary restrictions and increased physical activity.
People usually start Wegovy on a low dose which gradually increases over a 17 week period as patients grow more tolerant of its effects. As a result, the weight loss in the first 3 months can be gradual and in a smaller proportion to that seen over a 1-year period.
However this weight loss can still be significant with many users showing a 5-7% weight loss within the first 12 weeks when using Wegovy alongside lifestyle changes like reduced calorie diet and increased physical activity.
The effect of weight loss medications such as Wegovy depends on individual variation and some people can experience more or less weight loss in a given time period depending on factors such as metabolism and starting weight.
Please consult with your healthcare provider about healthy goals for Wegovy weight loss and how lifestyle changes can help supplement this process.
Fast, Discreet, and Convenient
We're here to support :)
We are available Monday through Friday from 9am to 4pm. Do not use this service if you need urgent assistance. You should call 111 or 999 in an emergency. See our help section for more information.
Payment Options
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |